Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

The evolution of biomarkers in rheumatoid arthritis: from clinical research to clinical care.

Expert opinion on biological therapy - 1 Nov 2008

van den Broek Theodorus, Tesser John R P, Albani Salvatore

Abstract excerpt

BACKGROUND: Treatment efficacy in rheumatoid arthritis (RA) has been measured by clinical response, gross radiological results and some biochemical markers. With the new biologic treatments, markers for disease development, progress, severity and therapy response have evolved. OBJECTIVES: This review focuses on a selection of current markers and the need for better markers for determining RA treatment...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Antirheumatic Agents
Share to Arthritis, Rheumatoid
Share to Autoantibodies

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Biomarkers

Share to Cartilage

Share to Immune System

Share to Inflammation

Share to Synovial Membrane

Source

Identifiers

PMID: 18847311
DOI: 10.1517/14712598.8.11.1773

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026. Manifest publication-graph-cohort-2026-09-07.1.

Source receipt: pubmed, retrieved 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

The evolution of biomarkers in rheumatoid arthritis: from clinical research to clinical care.PMID 18847311Read ↗

Biomarkers for rheumatoid arthritis: From molecular processes to diagnostic applications-current concepts and future perspectivesSemantic proximity Read ↗

Clinical Phenotypes, Serological Biomarkers, and Synovial Features Defining Seropositive and Seronegative Rheumatoid Arthritis: A Literature Review.Semantic proximity Read ↗

Biomarkers to Personalize the Treatment of Rheumatoid Arthritis: Focus on Autoantibodies and PharmacogeneticsSemantic proximity Read ↗

Prediction of Response to Targeted Treatment in Rheumatoid Arthritis.Semantic proximity Read ↗

Rheumatoid Arthritis Pathogenesis, Prediction, and Prevention: An Emerging Paradigm Shift.Semantic proximity Read ↗

Rheumatoid Arthritis: Biomarkers and the Latest BreakthroughsSemantic proximity Read ↗

Potential clinical biomarkers in rheumatoid arthritis with an omic approachSemantic proximity Read ↗

Assessing the potential of epigenetic targets as biomarkers in the diagnosis and treatment of rheumatoid arthritisSemantic proximity Read ↗

Rheumatoid arthritis: pathogenesis and therapeutic advancesSemantic proximity Read ↗

Immunological heterogeneity in rheumatoid arthritis: challenges in early-stage stratification, non-response to targeted therapy, and the restoration of immune tolerance.Semantic proximity Read ↗

Progress in the use of biochemical and biological markers for evaluation of rheumatoid arthritisSemantic proximity Read ↗

Frontiers in Rheumatoid Arthritis: Emerging Research and Unmet Needs in Pharmacologic ManagementSemantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.